Passage Bio, Inc. (PASG)
3.46
-0.05
(-1.42%)
USD |
NASDAQ |
Nov 05, 16:00
Passage Bio EPS Diluted (Quarterly) : -2.437 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.437 |
| March 31, 2026 | -2.358 |
| December 31, 2025 | -4.079 |
| September 30, 2025 | -2.438 |
| June 30, 2025 | -2.962 |
| March 31, 2025 | -0.248 |
| December 31, 2024 | -4.101 |
| September 30, 2024 | -0.3131 |
| June 30, 2024 | -0.2592 |
| March 31, 2024 | -0.2968 |
| December 31, 2023 | -0.305 |
| September 30, 2023 | -0.4948 |
| June 30, 2023 | -0.4362 |
| March 31, 2023 | -0.6287 |
| December 31, 2022 | -0.4957 |
| September 30, 2022 | -0.4902 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.7271 |
| March 31, 2022 | -0.7888 |
| December 31, 2021 | -0.9465 |
| September 30, 2021 | -0.8689 |
| June 30, 2021 | -0.8988 |
| March 31, 2021 | -0.7575 |
| December 31, 2020 | -0.8546 |
| September 30, 2020 | -0.6266 |
| June 30, 2020 | -0.5987 |
| March 31, 2020 | -0.9978 |
| December 31, 2019 | -0.2872 |
| September 30, 2019 | -4.973 |
| June 30, 2019 | -0.2932 |
| March 31, 2019 | -3.382 |
| December 31, 2018 | -0.1271 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.821M |
| Total Expenses (Quarterly) | 7.821M |
| Enterprise Value | -13.02M |
| Earnings Yield | -326.9% |
| Normalized Earnings Yield | -320.89 |